Innovation of the week: Earbuds that let you customize live music
New high-tech earbuds don't play music, but instead let wearers customize the world of sound around them, said Nathan McAlone in Business Insider. "Here" earbuds by New York–based Doppler Labs "are an audio geek's dream." Concertgoers can alter and add effects to live music, like turning up the bass or adding reverb for instant remixes. Doppler Labs has raised $17 million in venture capital, with investors including film composer Hans Zimmer and electronic dance music DJ Tiesto. Early on, the company touted the earbuds' ability to mute specific sounds, like a crying baby on an airplane. But as it prepares the earbuds to launch to the general public early next year, it's focusing on the ability to fine-tune live music, which is what many of its backers "were most excited about." Look for sponsored concerts that will showcase the technology.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
Today's political cartoons - May 4, 2024
Cartoons Saturday's cartoons - reflections in the pond, riding shotgun, and more
By The Week US Published
-
5 high-caliber cartoons about Kristi Noem shooting her puppy
Cartoons Artists take on the rainbow bridge, a farm upstate, and more
By The Week US Published
-
The Week Unwrapped: Why is the world running low on blood?
Podcast Scientists believe universal donor blood is within reach – plus, the row over an immersive D-Day simulation, and an Ozempic faux pas
By The Week Staff Published